PCDH9 suppresses melanoma proliferation and cell migration.

Zhang, Jiaojiao; Yang, Hui-Zhi; Liu, Shuang; Islam, Md Obaidul; Zhu, Yue; Wang, Zuhua; Chen, RongYi

Zhang, Jiaojiao; Yang, Hui-Zhi; Liu, Shuang; Islam, Md Obaidul; Zhu, Yue; Wang, Zuhua; Chen, RongYi.

Afiliación

Zhang J; Dermatology Department, Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Yang HZ; College of Food and Health, Zhejiang Agriculture and Forestry University, Hangzhou, Zhejiang, China.
Liu S; The Seventh Affiliated Hospital of Southern Medical University, Foshan, Guangdong, China.
Islam MO; Dermatology Department, Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Zhu Y; Department of Surgery, University of Miami, Miami, FL, United States.
Wang Z; College of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Chen R; Nano-drug Technology Research Center at Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.

Front Oncol ; 12: 903554, 2022.

Article en En | MEDLINE | ID: mdl-36452505

Palabras clave

CCND1 (Cyclin D1); MMP2; MMP9; PCDH9; RAC1; melanoma cell suppression

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google